Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines
Bergman, A.M.; Pinedo, H.M.; Veerman, G.; Kuiper, C.M.; Peters, G.J.
Advances in Experimental Medicine and Biology 431: 591-594
1998
ISSN/ISBN: 0065-2598 PMID: 9598134 Document Number: 489116
Document emailed within 1 workday
Related Documents
Carney, D.N.; Mitchell, J.B.; Kinsella, T.J. 1983: In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants Cancer Research 43(6): 2806-2811Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Sekido, Y.; Takahashi, T.; Ueda, R.; Takahashi, M.; Suzuki, H.; Nishida, K.; Tsukamoto, T.; Hida, T.; Shimokata, K.; Zsebo, K.M. 1993: Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene Cancer Research 53(7): 1709-1714
Loh, P.M.; Clamon, G.H.; Robinson, R.A.; White, M.L.; Hukku, B.; Rossi, N.P.; Peterson, W.D. 1984: Establishment and characterization of four new human non-small cell lung cancer cell lines Cancer Research 44(8): 3561-3569
Mitsudomi, T.; Oyama, T.; Gazdar, A.F.; Minna, J.D.; Okabayashi, K.; Shirakusa, T. 1992: Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance Nihon Geka Gakkai Zasshi 93(9): 944-947
Recanatini, E.; Marcheggiani, F.; Corinaldesi, G.; Gazzanelli, G.; Saccucci, F.; Possati, L. 1993: Establishment and characterization of two human small cell lung carcinoma cell lines Bollettino della Societa Italiana di Biologia Sperimentale 69(2): 129-135
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Berendsen, H.H.; de Leij, L.; de Vries, E.G.; Mesander, G.; Mulder, N.H.; de Jong, B.; Buys, C.H.; Postmus, P.E.; Poppema, S.; Sluiter, H.J. 1988: Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up Cancer Research 48(23): 6891-6899
Yokoyama, T.; Miyazawa, K.; Yoshida, T.; Ohyashiki, K. 2005: Combination of vitamin K2 plus imatinib mesylate enhances induction of apoptosis in small cell lung cancer cell lines International Journal of Oncology 26(1): 33-40
Postmus, P.E.; Schramel, F.M.; Smit, E.F. 1998: Evaluation of new drugs in small cell lung cancer: the activity of gemcitabine Seminars in Oncology 25(4 Suppl 9: 79-82
Cucević, B.; Samarzija, M.; Baricević, D.; Jakopović, M.; Redzepi, G.; Samija, M. 2005: Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer Collegium Antropologicum 29(2): 583-588
Furuse, K. 1999: Gemcitabine in the treatment of non-small cell lung cancer for elderly patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 890-897
Thatcher, N.; Jayson, G.; Bradley, B.; Ranson, M.; Anderson, H. 1997: Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer Seminars in Oncology 24(3 Suppl 8: S8
Thongprasert, S.; Chewaskulyong, B.; Pothirat, C. 2001: Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer Journal of the Medical Association of Thailand 84(3): 397-401
Casero, R.A.; Mank, A.R.; Xiao, L.; Smith, J.; Bergeron, R.J.; Celano, P. 1992: Steady-state messenger RNA and activity correlates with sensitivity to N1,N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer Cancer Research 52(19): 5359-5363
Wolf, H.; Jassem, E.; Cynowska, B.ła.; Damps, I.; Mierzejewska, E.; Słomiński, J.M. 2002: Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin Pneumonologia i Alergologia Polska 70(1-2): 44-51
Ettinger, D.S. 2000: Gemcitabine/Alimta in locally advanced or metastatic non-small-cell lung cancer Oncology 14(7 Suppl 4: 49-52
Le Chevalier, T. 1996: Single-agent activity of gemcitabine in advanced non-small cell lung cancer Seminars in Oncology 23(5 Suppl 10: 36-42
Yokoyama, A. 1999: Gemcitabine hydrochloride is a new anti-cancer agent which will be available in the patients with non-small cell lung cancer (NSCLC) in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 908-915
Chen, X.; Lai, M-de.; Huang, Q. 2002: Increased sensitivity of colorectal cancer cell lines with microsatellite instability to 5-fluorouracil in vitro Chinese Medical Journal 115(7): 1048-1052